Analyst Mani Foroohar of Leerink Partners maintained a Buy rating on RegenXBio (RGNX – Research Report), boosting the price target to $38.00. Don't Miss our Black Friday Offers: Discover the latest ...
Glenview CEO Larry Robbins will take a seat on the CVS Health board. The company also will add H2 Health Chairman and CEO Guy ...
On Friday, MannKind Corp (MNKD) stock saw a decline, ending the day at $6.8 which represents a decrease of $-0.22 or -3.13% from the prior close of $7.02. The stock opened at $7.05 and touched a low ...
CVS Health said on Monday it added four new members to its board including hedge fund Glenview Capital's chief executive Larry Robbins as part of a standstill agreement with the activist investor. The ...
On Friday, Gilead Sciences, Inc. (GILD) stock saw a decline, ending the day at $88.4 which represents a decrease of $-3.71 or -4.03% from the prior close of $92.11. The stock opened at $91.71 and ...
Leerink Partners and Cantor acted as placement agents in connection with the private placement. Don't Miss our Black Friday Offers: Published first on TheFly – the ultimate source for real-time, ...
Robert F. Kennedy Jr.'s nomination to lead HHS is causing cautious concern among investors. Here's which companies and stocks ...
Investor's Business Daily on MSN8h
How A Side Effect Has Wiped Out Nearly 73% Of Neurogene's Value In A WeekNeurogene stock collapsed, again, on Monday after the company scrapped the high dose of its experimental Rett Syndrome ...
HC Wainwright restated their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a research report released on Friday morning,Benzinga reports. The firm currently has a $27.00 price target ...
CVS Health added Glenview Capital's top boss and three others to its board in a deal with the hedge fund, a month after the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback